Pharmion Corporation
NASDAQ: PHRM Acquired By: Celgene Corporation

Biotechnology company focused on acquiring, developing and commercializing innovative products in hematology and oncology.

Sector: Healthcare, Biopharmaceuticals
Company Status: IPO, Public
Investment Status: Historical